About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

ASKA Pharmaceutical Holdings Co.,Ltd.(4886) Summary

4886
TSE Prime
ASKA Pharmaceutical Holdings Co.,Ltd.
2,300
JPY
-24
(-1.03%)
May 1, 3:30 pm JST
15.95
USD
May 1, 2:30 am EDT
Result
PTS
outside of trading hours
2,301.8
May 1, 3:23 pm JST
Summary Chart Historical News Financial Result
PER
13.0
PBR
1.00
Yield
2.17%
Margin Trading Ratio
14.39
Stock Price
May 1, 2025
Opening May 1, 9:00 am
2,324 JPY 16.24 USD
Previous Close Apr 30
2,324 JPY 16.30 USD
High May 1, 9:00 am
2,324 JPY 16.24 USD
Low May 1, 3:18 pm
2,299 JPY 15.94 USD
Volume
21,600
Trading Value
0.05B JPY 0.35M USD
VWAP
2306.61 JPY 15.99 USD
Minimum Trading Value
230,000 JPY 1,595 USD
Market Cap
0.07T JPY 0.46B USD
Number of Trades
106
Liquidity & Number of Trades
As of May 1, 2025
Liquidity
Mid
1-Year Average
306
1-Year High May 13, 2024
1,910
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 25, 2025 5,400 25,700 4.76
Apr 18, 2025 4,800 21,200 4.42
Apr 11, 2025 5,200 23,400 4.50
Apr 4, 2025 4,900 32,600 6.65
Mar 28, 2025 5,800 43,800 7.55
Company Profile
ASKA Pharmaceutical Holdings Co., Ltd. specializes in gynecology and urology, with hormone preparations as its main products. The company sells generic drugs for Takeda and also develops new drugs.
Sector
Pharmaceuticals
ASKA Pharmaceutical Holdings Co., Ltd. focuses on the pharmaceutical business as its core, while also operating in animal health and clinical testing sectors. In the pharmaceutical business, "Aska Pharmaceutical" specializes in products for internal medicine, obstetrics and gynecology, and urology, which are distributed through Takeda Pharmaceutical Company. The animal health business is managed by "Aska Animal Health," which procures some products from Aska Pharmaceutical while also outsourcing manufacturing to Aska Pharmaceutical. The clinical testing business is operated by "Aska Pharmaceutical Medical," which leases facilities from Aska Pharmaceutical for its operations. Additionally, Aska Pharmaceutical handles the procurement and sales of medical devices and health foods. The company has adopted a holding company structure to manage its group companies effectively.